Study of Bevacizumab and Erlotinib in Patients With Advanced Non-small Cell Lung Cancer
Clinical trial NCT00553800 · COMPLETED
Trial details
- NCT number
- NCT00553800
- Sponsor
- Fox Chase Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-07-05
- Primary completion
- 2011-01-12
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.